The brain cells are segregated from lipoproteins in the systemic circulation by the blood-brain barrier, so that cholesterol homeostasis in the brain is dependent on its specific extracellular lipid transport system by apolipoproteins and lipoproteins (1) (2) (3) (4) (5) . Helical apolipoproteins such as apolipoprotein E (apoE), apoA-I, apoD, apoA-IV, and apoJ have been identified in the cerebrospinal fluid as components of HDL, but the main apolipoproteins are apoE and apoA-I (6-10). The phenotype of human brain apoE does not change after liver transplantation, so that brain apoE is mostly produced in the brain (11) .
It is known that apoE is produced mainly by astrocytes and partly by microglia in the brain, suggesting that astrocytes play an important role in cholesterol homeostasis in the central nervous system (5, 10, (12) (13) (14) (15) (16) . Astrocytes produce cholesterol-rich HDL with cellular lipid by autologously synthesized apoE (8, 17) . They also react with exogenous apoA-I to generate cholesterol-poor HDL through a unique system for intracellular cholesterol transport (18) (19) (20) . Like plasma HDL, ATP binding cassette transporter A1 supports such production of brain HDL, although other pathways may also function as backup systems (21, 22) . These lipoproteins are thought to play important roles in intercellular lipid transport in the brain. It has been noted that apoE synthesis is upregulated in the brain during development and after injury (13, (23) (24) (25) (26) (27) (28) (29) (30) (31) , and this reaction is likely to be involved in the healing process of the injury (32) (33) (34) (35) .
Four types of apoE binding receptor are identified in the brain: very low density lipoprotein receptor, low density lipoprotein receptor, low density lipoprotein receptorrelated protein, and apoE receptor-2; thus, apoE is thought to function as a recognition site of lipoproteins for lipid delivery among brain cells (36, 37) . However, some of them are also likely to mediate signals for the migration of brain cells during the developmental integration of the brain (38) .
We reported previously that astrocytes prepared by 1 month primary culture of rat fetal brain cells and subsequent 1 week secondary culture (M/W cells) synthesized and secreted apoE and cholesterol more actively than astrocytes prepared according to the conventional method of 1 week primary and 1 week secondary culture (W/W cells) (39) . A fibroblast growth factor-1 (FGF-1)-like factor is secreted by the long-cultured rat fetal brain cells, and their conditioned media stimulated W/W astrocytes for the secretion of apoE. We also found that FGF-1 is produced by astrocytes adjacent to the cryoinjury lesions of mouse brain before the increase of apoE synthesis in vivo (40) . We identified a promoter polymorphism of FGF-1 related to risk for Alzheimer's disease (41) . Thus, we hypothesize that FGF-1 is a trigger stimulant of apoE synthesis and generation of HDL in the postinjury brain, presumably by an autocrine mechanism. In the present work, we attempted to identify the cells that secrete FGF-1 in the culture system and demonstrate an autocrine mechanism for this factor to stimulate apoE-HDL production. This is an important process to identify the triggering mechanism for the production of apoE and its HDL in the postinjury brain for recovery from damage.
MATERIALS AND METHODS

Preparation of fetal rat astrocytes
Astrocytes were prepared from the 17 day fetal brain of Wistar rats according to the method previously described (42) . After removal of the meninges, the brain was cut into small pieces and treated with 0.1% trypsin solution in Dulbecco's phosphate-buffered saline (DPBS) containing 0.15% glucose (0.1% trypsin/ DPBS/G) for 3 min at room temperature. The cell pellet by centrifugation at 1,000 rpm for 3 min was cultured in F-10 medium containing 10% fetal calf serum (10% FCS/F-10) at 37 Њ C for 4 weeks as a primary culture. After treatment with 0.1% trypsin/ DPBS/G containing 1 mM ethylenediaminetetraacetic acid, the cells were cultured in 10% FCS/F-10 for 1 week as a secondary culture (M/W cells). Alternatively, astrocytes were prepared by a conventional method of 1 week primary and subsequent 1 week secondary culture (W/W cells). Both preparations contained 95% astrocytes [glial fibrillary acidic protein (GFAP)-positive], 0.3% oligodendroglias (anti-myelin basic protein-positive), and 3% microglias (ED-1-positive) (39) .
Synthesis and release of cellular cholesterol
Rat astrocytes at a confluent stage were washed with DPBS four times and incubated in 0.1% BSA/F-10 for 24 h. The cells were incubated with [ 3 H]acetate (New England Nuclear) in fresh 0.02% BSA/F-10 for certain periods of time. For the lipid-release experiments, the cells were washed three times with cold DPBS and further incubated in fresh 0.02% BSA/F-10 in the presence of 1 mM acetate. Cholesterol was extracted from the cells and the conditioned medium with hexane-isopropanol (3:2, v/v) and chloroform-methanol (2:1, v/v), respectively, and separated by TLC on Silica Gel-60 plates (E. Merck, Darmstadt, Germany). Radioactivity in the cholesterol fraction was counted (43) . The medium was also analyzed by density gradient ultracentrifugation as described previously (17) . After removing cell debris by centrifugation, the medium (8 ml) was overlaid on the sucrose solution (d ϭ 1.175; 17 ml) and centrifuged at 1 ϫ 10 5 g for 48 h. Samples were fractionated and analyzed for cholesterol mass by the enzymatic colorimetric method (44) and for apoE by Western blotting (see below).
Analysis of cell and medium protein by Western blotting
The cells were harvested with a rubber policeman after washing four times with DPBS. The cell pellet by centrifugation at 1,000 rpm for 10 min was treated with cold and salined 0.02 M Tris-HCl buffer, pH 7.5 (TBS), containing the protease inhibitor cocktail (Sigma) for 10 min with 25 agitations for 10 s every 5 min. The suspension was centrifuged at 3,000 rpm for 10 min for removal of nuclei and cell debris. The supernatant was sonicated and centrifuged at 370,000 g for 30 min to obtain supernatant as a cell protein extract fraction. Cell debris was removed from the conditioned medium by centrifugation at 15,000 rpm for 30 min. Protein in the cell extract or in the conditioned medium was precipitated by 10% trichloroacetate and centrifugation at 15,000 rpm for 20 min, separated by SDS-PAGE, and transferred to a SequiBlot™ polyvinylidene difluoride membrane (Bio-Rad). The membrane was immunostained with a goat anti-FGF-1 antibody (Santa Cruz Biotechnology) and a rabbit antibody against rat apoE, a generous gift from Dr. Jean Vance (University of Alberta).
Reverse transcription-polymerase chain reaction
Total cellular RNA was extracted from rat astrocytes with Isogen (Wako Life Science) and reverse-transcribed to generate cDNA in a SuperScript Preamplification System (Gibco BRL). The cDNA was subjected to PCR using the DNA probes for rat apoE mRNA and FGF-1 mRNA as described in the previous paper (39) . After electrophoresis of the products, an agarose gel was stained with freshly prepared SYBR Gold nucleic acid gel stain solution. The band was detected by an ultraviolet transilluminator (UVP NLM-20E) at 302 nm. The apoE primer pairs were 5 Ј -GCGCACCTCCTC-CATCTCCTC-3 Ј (sense) and 5 Ј -AGGATCTATGCAACCGACTCG-3 Ј (antisense). The FGF-1 primers were 5 Ј -AAGCCCGTCGGTGT-CCATGG-3 Ј and 5 Ј -GATGGCACAGTGGATGGGAC-3 Ј .
Immunocytostaining of astrocytes
Astrocytes on a tissue culture chamber/slide (Mikes Scientific) were washed with DPBS and fixed with 100% methanol at Ϫ 20 Њ C for 30 min. The cells were treated with 1% Triton X-100 in 0.02 M phosphate buffered saline at room temperature for 2 min after washing with DPBS. The cells were washed with DPBS again, treated with goat anti-FGF-1 antibody, or rabbit anti-rat apoE antibody, at room temperature for 60 min and washed. After incubation with biotin-conjugated anti-goat IgG, or anti-rabbit IgG antibody (Histofine) for 30 min at room temperature, the cells were washed, treated with peroxidase-conjugated streptavidin (Histofine) for 15 min, and then washed. The cells were stained by reaction with 0.01% 3,3 Ј -diaminobenzidine tetrahydrochloride (Dojindo)/0.03% H 2 O 2 /0.05 M Tris buffer, pH 7.5, for 5 min at room temperature.
Alternatively, M/W astrocytes were fluorescence immunostained after being fixed in organic solution composed of methanol, chloroform, and acetic acid (6:3:1) at Ϫ 20 Њ C for 3 h. After washing with cold TBS, the cells were reacted with either goat anti-FGF-1 or goat anti-rat apoE antibody (Santa Cruz Biotechnology) and mouse anti-GFAP antibody (BD Transduction Laboratories) in TBS containing 3% donkey serum and 3% horse serum at room temperature for 1 h. The cells were reacted with rhodamine-conjugated donkey anti-goat IgG antibody (Chemicon International) or fluorescein-conjugated horse anti-mouse IgG antibody (Vector Laboratories) in the presence of 3% donkey or at PENN STATE UNIVERSITY, on February 23, 2013 www.jlr.org Downloaded from 3% horse serum, respectively, at room temperature for 1 h after washing three times with TBS. The cells were observed by laser scanning confocal microscopy (LSM5; Zeiss, Jena, Germany).
Analysis of signaling pathways
For the analysis of the FGF-1-initiated signals to stimulate apoE synthesis, rat astrocytes (W/W cells) were washed, replaced with 0.1% BSA/F-10, and incubated for 24 h with FGF-1 (50 ng/ ml) in the presence or absence of an inhibitor of phosphoinositide 3-OH kinase (PI3K), for PI3K, LY294002 (10 M; Calbiochem), or an inhibitor of MEK, U0126 (10 M; Calbiochem). The cells were further incubated in the same condition in fresh 0.02% BSA/F-10 for 8 h and then in 0.02% BSA/F-10 for 16 h after washing. The conditioned medium was centrifuged at 15,000 rpm for 60 min to remove cell debris, treated with 10% TCA, and centrifuged at 15,000 rpm for 20 min. The pellet was analyzed by SDS-PAGE and Western blotting using rabbit anti-rat apoE antibody. Phosphorylation of Akt by FGF-1 was also examined. After the cells were incubated with FGF-1 (50 ng/ml) in fresh 0.02% BSA/F-10 for 5 min, the cytosol was prepared as a supernatant of the cell treatment in 0.02 M Tris-HCl buffer, pH 7.5, containing protease inhibitor cocktail (Sigma) for 10 min with 10 s of agitation 25 times every 5 min and centrifugation at 90,000 rpm for 30 min. The cytosol protein precipitated with 10% TCA was analyzed by SDS-PAGE and Western blotting using mouse antiprotein kinase B (PKB) ␣ /Akt antibody (BD Transduction Laboratories) and rabbit anti-phospho-Akt (Thr-308) antibody (Cell Signaling Technology).
RESULTS
During long-term culture of the rat brain cells, a large number of neurites were identified at 1 week, and astrocytes became predominant after 2-3 weeks, when neurons were hardly identified ( Fig. 1A ) . Expression of the FGF-1 message was not apparent at 1 week primary culture and was markedly increased after 3 weeks (Fig. 1B) . These findings indicated that FGF-1 was produced by astrocytes rather than neurons during the long-term primary culture of brain cells.
To identify the cells that produce FGF-1 and apoE more specifically, immunostaining was performed for FGF-1 and apoE in various astrocyte preparations by 1 week secondary culture after primary culture of the brain cells for 1, 2, and 4 weeks ( Fig. 2 ) . The increase of FGF-1 and apoE was observed in cells prepared after primary culture for both 2 and 4 weeks ( Fig. 2A-C, 2E-G) . In the astrocyte preparation of 4 week primary and 1 week secondary culture (M/W cells), a group of cells were found with an appearance of "type 2" astrocyte-like cells. Both proteins were also identified in these cells (Fig. 2D, H) .
M/W cells were further analyzed by fluorescence immunostaining to confirm that both FGF-1 and apoE were produced by astrocytes. Figure 3 shows that FGF-1 and apoE were both immunochemically identified in the GFAP-positive cells.
M/W cells were examined for the production and secretion of FGF-1. The conditioned media of the brain cell primary culture and of the astrocyte preparations were examined for effects on the astrocytes prepared by a conventional method of 1 week primary and 1 week secondary culture (W/W cells) ( Fig. 4 ) . The medium of the primary culture for 2, 3, and 4 weeks and that of M/W cells stimulated apoE secretion from W/W cells (Fig. 4A) . The astrocytes after 1 week primary and 4 week secondary culture (W/M cells) also generated the conditioned medium to stimulate apoE secretion. Stimulation of cholesterol release from W/W cells by M/W cell-conditioned medium was neutralized by pretreatment of the medium with anti-FGF-1 antibody-Sepharose and with heparin-Sepharose (Fig. 4B) . This finding is consistent with the results with the conditioned medium of long-cultured whole brain cells (39) .
The effect of FGF-1 was further analyzed in the experiments shown in Fig. 5 . Density gradient analysis of the medium revealed an increase of HDL production by astrocytes (W/W cells) when stimulated by FGF-1 (Fig. 5A) . There was no shift of the density peak of HDL with this change. Figure 5B demonstrates the distribution of apoE in the density fractions. The increase of apoE by FGF-1 was observed coincidentally with the cholesterol peak.
The message and protein of FGF-1 in M/W astrocytes were examined. M/W cells expressed a greater level of FGF-1 mRNA than did W/W cells ( Fig. 6A ). On the other hand, a similar amount of FGF-1 was detected as a 16.5 kDa protein in the heparin-bound fraction of the extracts Total cellular RNA was prepared with Isogen (Wako Life Science) from brain cells in primary culture for 1 week (1W/P), 3 weeks (3W/P), and 4 weeks (4W/P) and from astrocytes prepared by conventional 1 week primary and 1 week secondary culture (W/W). Total mRNA (5 g) was reverse-transcribed to cDNA using the SuperScript Preamplification System (Gibco BRL) for 10 min at 25ЊC, for 50 min at 50ЊC, and for 15 min at 70ЊC, and 0.5 g of cDNA product was amplified using FGF-1 primers (5Ј-AAGCCCGTCGGT-GTCCATGG-3Ј and 5Ј-GATGGCACAGTGGATGGGAC-3Ј) for 30 cycles.
at PENN STATE UNIVERSITY, on February 23, 2013 www.jlr.org of both W/W and M/W cells by Western blotting analysis using an anti-FGF-1 antibody (Fig. 6B) . However, a much greater amount of this protein was secreted into the culture medium by M/W cells than by W/W cells, as identified by immunoprecipitation with anti-FGF-1 antibody (Fig. 6C) . Furthermore, secretion of apoE by M/W cell was markedly decreased when the cells were exposed to an anti-FGF-1 antibody during the detection period ( 6D). Thus, we concluded that M/W astrocytes produce and secrete FGF-1 and that the secreted FGF-1 stimulates the cells to produce and secrete apoE by an autocrine mechanism.
Signaling pathways for the stimulation of apoE synthesis by FGF-1 were examined. The increase of apoE secretion by FGF-1 was suppressed by LY294002, a PI3K/Akt inhibitor, but not by U0126, a MEK inhibitor ( Fig. 7A ) . Phosphorylation of Akt in cytosol was in fact induced by FGF-1 (Fig.  7B) . Thus, FGF-1 stimulates apoE synthesis via the PI3K/ Akt pathway rather than by the Ras/MEK/Erk pathway.
DISCUSSION
We previously reported that FGF-1-like factor is secreted by 4 week primary cultured rat brain cells into the culture medium and enhances the production and secretion of apoE and cholesterol/phospholipid in W/W cells (39) . We also discovered in vivo that FGF-1 is produced before the production of apoE in astrocytes after cryoinjury of the mouse brain (40) . From these findings, we hypothesized that FGF-1 is one of the trigger factors for the production and release of apoE and apoE-HDL in astrocytes after brain injury and that it is released by astrocytes themselves to carry this reaction in an autocrine manner. In the present study, we further investigated this reaction in vitro to demonstrate that astrocytes are in fact capable of releasing FGF-1 and autostimulating apoE-HDL production.
The results summarized below led us to conclude that M/W astrocytes release FGF-1 and stimulate the production of apoE-HDL by an autocrine reaction. 1 ) The astrocytes prepared by 1 month primary and 1 week secondary Among the several cytokines examined for the stimulation of apoE synthesis and secretion in human astrocytes, epidermal growth factor stimulated apoE secretion, whereas interleukin 1 ␣ and 1 ␤ , interferon ␥ , and FGF-2 did not (45) . In our previous work, we examined the effect of FGF-1, FGF-2, insulin, and interleukin 1 ␤ in rat astrocytes, and only FGF-1 stimulated the synthesis and secretion of apoE and lipid in rat astrocytes (39) . FGF-1-like activity was found in the conditioned medium of brain cell culture to stimulate the astrocytes in the same manner. Our finding that FGF-1 is produced in astrocytes before the production of apoE in the brain injury lesion strongly supported the idea of its important role in the healing process. It has been thought that FGF-1 is primarily synthesized by neurons in vivo, but astrocytes are also identified as a potential source (46) (47) (48) (49) (50) (51) (52) . The present results indicate that astrocytes are the main source of FGF-1 for the stimulation of apoE-HDL production by an autocrine mechanism.
Epidermal growth factor increases apoA-I expression in human hepatoma cells (HepG2) through the Ras-MAP kinase cascade and Sp1 (53) . FGF-1 is known to induce signaling through P21ras/Erk (54, 55) and PI3K/Akt (56) in cells, including astrocytes. The present experiments using Total cellular RNA was prepared from the cells, and RT-PCR was carried out using FGF-1 primer pairs with 28 cycles as described for Fig. 1 . B: FGF-1 in astrocytes. Three milliliters of cell extract (250 g of cytosol proteins/ml) was prepared from W/W and M/W astrocytes by sonication of the cells in TBS containing protease inhibitor cocktail (Sigma). The cell extract was mixed with heparin-Sepharose at room temperature for 2 h. The gel was washed three times with TBS containing protease inhibitor cocktail and applied for SDS-PAGE and Western blot analysis using goat anti-FGF-1 antibody. The left two lanes represent standard FGF-1. C: FGF-1 secreted into the conditioned medium of astrocytes. W/W and M/W cells (797 and 1,320 g of total cell protein, respectively), each in two 10 cm Petri dishes, were metabolically labeled with 500 Ci/0.5 nM [ 35 S]methionine in 7 ml of 0.02% BSA/F-10 without methionine or cysteine for 10 h and washed four times. After the cells were incubated in fresh 0.02% BSA/F-10 for 16 h, the conditioned medium equivalent to 690 g/ cell protein was collected. FGF-1 was immunopurified using goat anti-FGF-1 antibody-bound protein G-Sepharose and analyzed by SDS-PAGE and autoradiography. D: Effect of FGF-1 antibody in the culture medium on apoE secretion by astrocytes. M/W cells were exposed to anti-FGF-1 antibody (Santa Cruz Biotechnology) at the indicated concentration in fresh 10% FCS/F-10 at 3, 5, and 7 days after subculture. The culture medium (equivalent to 45 g of cell proteins) was collected at the end of the 7th day and analyzed by SDS-PAGE and Western blotting using an anti-rat apoE antibody. inhibitors of these pathways preliminarily indicate that apoE synthesis is stimulated by FGF-1 via the PI3K/Akt pathway. It is still unknown how this signaling regulates apoE gene expression. On the other hand, the apoE gene is upregulated by liver X receptor/retinoid X receptor in macrophages/adipocytes (57), fibroblasts (58) , and astrocytes (59) . Thus, the present results do not exclude the possibility that FGF-1 may indirectly upregulate apoE gene expression via the enhancement of cholesterol metabolism. The involvement of cAMP-and protein kinase C (PKC)-related pathways was also suggested for apoE upregulation (60) .
It is puzzling how FGF-1 is released by cells even without a signal peptide. FGF-9 produced in the brain and kidney is also secreted by cells in spite of the lack of a signal peptide (61) . As FGF-9 is an N -glycosylated protein, it is thought to be processed and secreted via the Golgi apparatus. The FGF-1-transfected cells release FGF-1 into the culture medium only in heat-shock conditions (62) . FGF-1 may thus be secreted by astrocytes under stress to stimulate the secretion of apoE-HDL, such as heat shock, oxidation, and long-term culture, as described in this work. These stress conditions may be related to the brain damage.
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